A recent report published in Science Translational Medicine by MUSC Hollings Cancer Center investigator Sophie Paczesny, M.D., Ph.D., sheds light on immune cell biomarkers that may reveal which patients are most at risk for ...
Oct 7, 2020
0
40
Many plants contain bioactive ingredients that can alleviate human diseases. These phytocompounds often contain restorative biological properties such as anti-cancerous, antioxidant and anti-inflammatory effects. Thus, understanding ...
Sep 24, 2020
1
31
Most people are aware that testing for antibodies in a person's blood can show if someone has had a specific disease, such as COVID-19. Those antibodies provide protection from getting the disease again.
Aug 27, 2020
0
1
A research team highlights the mechanisms underlying memory and learning capacity—specifically, how our brains process, store and integrate information.
Aug 26, 2020
0
112
To confront the many challenges that infectious diseases pose to mankind head-on, a multi-disciplinary team of bioengineers, materials-scientists and immunologists at Harvard's Wyss Institute has developed a broadly deployable ...
Aug 20, 2020
0
8
The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to ...
Aug 7, 2020
0
243
Cold Spring Harbor Laboratory (CSHL) Associate Professor Mikala Egeblad and her colleagues describe a newly understood way by which breast cancer cells sabotage a key player in the body's immune system. That key player provides ...
Jul 15, 2020
0
1
Eating black raspberries might reduce inflammation associated with skin allergies, a new study indicates.
Jul 2, 2020
0
283
A significant site of damage during COVID-19 infection is the lungs. Understanding how the lungs' immune cells are responding to viral infections could help scientists develop a vaccine.
Jun 11, 2020
0
13
Adoptive T cell therapies, including chimeric antigen receptor (CAR) T cell therapy, which use genetically engineered killer immune T cells, are emerging forms of immunotherapy that redirect the immune system to target cancer.
May 19, 2020
0
80
